# The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review

**Authors:** Giuseppina Malcangi, Angelo Michele Inchingolo, Lucia Casamassima, Irma Trilli, Laura Ferrante, Marialuisa Longo, Francesco Inchingolo, Grazia Marinelli, Andrea Palermo, Gianna Dipalma, Alessio Danilo Inchingolo

PMC · DOI: 10.3390/ijms27020700 · 2026-01-09

## TL;DR

This review summarizes how astaxanthin reduces inflammation and oxidative stress in humans, showing potential benefits for metabolic, reproductive, and cardiovascular health.

## Contribution

The study systematically reviews recent human trials to highlight astaxanthin's antioxidant and anti-inflammatory effects across multiple health domains.

## Key findings

- Astaxanthin reduced pro-inflammatory cytokines and oxidative stress while boosting antioxidant capacity in human studies.
- Combined astaxanthin and exercise improved body composition, lipid profiles, and insulin sensitivity.
- In women with PCOS or endometriosis, astaxanthin improved oocyte and embryo quality by downregulating stress-related pathways.

## Abstract

This systematic review aimed to summarize the effects of astaxanthin (ASX) supplementation on oxidative stress, inflammation, and metabolic regulation in human studies. A systematic search was conducted in Scopus, Web of Science (WOS), and PubMed for articles published between 2020 and 2025. Fifteen studies involving human participants were included, while in vitro and animal studies were excluded. ASX consistently reduced pro-inflammatory cytokines (IL-6, TNF-α, TGF-β1) and oxidative stress indices while increasing antioxidant capacity (SOD, TAC). Combined ASX and exercise interventions improved body composition, lipid profiles, insulin sensitivity, and immune recovery. In women with Polycystic Ovary Syndrome (PCOS) or endometriosis, ASX downregulated endoplasmic reticulum stress–related apoptotic pathways and improved oocyte and embryo quality. Cardiometabolic and respiratory outcomes showed improved endothelial function and reduced disease severity. Astaxanthin demonstrates broad antioxidant and anti-inflammatory properties, supporting its role as a promising adjunctive therapy for metabolic, reproductive, and cardiovascular health. Further well-designed clinical trials are needed to confirm optimal dosing and mechanisms of action.

## Linked entities

- **Proteins:** IL6 (interleukin 6), TNF (tumor necrosis factor), TGFB1 (transforming growth factor beta 1), SOD1 (superoxide dismutase 1), Tac1 (tachykinin, precursor 1)
- **Chemicals:** astaxanthin (PubChem CID 5281224)
- **Diseases:** Polycystic Ovary Syndrome (MONDO:0008487), endometriosis (MONDO:0005133)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** PCOS (MESH:D011085), endometriosis (MESH:D004715), Inflammatory (MESH:D007249)
- **Chemicals:** lipid (MESH:D008055), ASX (MESH:C005948)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12840775/full.md

---
Source: https://tomesphere.com/paper/PMC12840775